evaluation of decreasing pain of impacted wisdom teeth

Comparison of Gelophen administration on mandibular impacted third molar surgery on pain reduction after surgery between men and women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180702040302N1

Enrollment

Registered

2018-08-01

Start date

2017-04-11

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain control. F45.4 Persistent somatoform pain disorder

Interventions

Intervention group: Two Gelofen 400 mg 1 hours after impacted wisdom teeth.

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Impacted mandibular third molar Third molar without caries Third molar without a pericoronitis A lack of vision of the impacted molar with the eye An impacted molar that requires surgery to remove the need for piece of bone and teeth

Exclusion criteria

Exclusion criteria: Having a history of disease History of digestive diseases History of systemic diseases such as diabetes, kidney failure, liver failure History of allergy to aspirin and its similar compounds Patients with a history of addiction No-referral Non-response of the phone for any reason Incidence of severe complications and patient death, Use of drugs with anti-pain and anti-inflammatory properties that interfere with NSAIDs.

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: 2,4,6,6,8, 12,24,72 hours after surgery. Method of measurement: Standard questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mosayeb Masoumi Nejad

Larestan University of Medical Sciences

neda_amani69@yahoo.com+98 21 3320 7826

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026